WR1 General Discussion, page-87

Hardly surprising since there aren't likely to be any fresh assay results before February. Unfortunately punters need a good reason to buy stocks and without impressive assay results what else is likely to motivate buying? It reminds me of my first purchase in CXO at 13c in 2016. From there it spiralled downwards and basically remained in the 4-5c range for four years before taking off big time. Whilst there are similarities there are also differences, though. During that four year period the spodumene price fell and remained below viability, whereas at present it's very healthy and almost certain to remain viable into the future even if it falls somewhat. I think all will be well as long as the drill bit confirms adequate resources. It might take 18 months or a little longer, that's all. Then we might see a $1 SP.